Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

Clinical trial NCT00374933 · COMPLETED

Trial details

NCT number: NCT00374933
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome

Start date: 2007-04-01
Primary completion: 2009-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.